ATTR Cardiac Amyloidosis
David Wolinsky, MD, Director of the Cardiac Amyloid Clinic at the Cleveland Clinic in Weston, FL, delves into the details of transthyretin amyloidosis (ATTR) and its impact on the heart.
▶︎
Mathew Maurer, MD, FACC | Cardiac Amyloidosis
▶︎
Cardiac Amyloidosis: Update on Diagnosis and Treatment
▶︎
Wild-Type Transthyretin Cardiac Amyloidosis - Mayo Clinic
▶︎
EP Lab Tour: Dr. Brett Gidney provides an overview of catheter ablation
▶︎
Cardiac Amyloidosis: The Heart of the Matter
▶︎
Medical Stories - Hereditary Amyloidosis (HA) Dylan's Story
▶︎
Patient Webinar: 8 Must-Know Tips for Heart Valve Disease Patients
▶︎
10 - Neurological Presentations of ATTR | Updates in Cardiac Amyloidosis 2023
▶︎
hATTR Amyloidosis: You and Your Family
▶︎
Cardiac Amyloidosis Interpretation Best Practices
▶︎
Cardiac Amyloidosis: An Underdiagnosed, Not Rare Disease | DoM Grand Rounds | 15 Feb 2023
▶︎
Understanding Cardiac Amyloidosis: Evaluation and Diagnosis w/ Mathew S. Maurer, MD
▶︎
Cardiac Amyloidosis No longer rare and untreatable - Bell-Ezziddine
▶︎
Imaging in Heart Failure: Where Are We and What is Coming? (Y.S. Chandrashekhar, MD)
▶︎
Cardiac Amyloidosis Webinar
▶︎
Myelodysplastic Syndromes and Secondary AML– Update on Diagnosis and Treatment
▶︎
Mayo Clinic Q&A podcast: Symptoms for cardiac amyloidosis overlap with other conditions
▶︎
The Complete Cardiology Masterclass: Exam-Ready in One Video
▶︎
Cardiac Amyloidosis by Dr. Mat Maurer
▶︎